These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13064223)

  • 1. Evidence for lipolytic action by human plasma obtained after intravenous administration of heparin.
    SHORE B; NICHOLS AV; FREEMAN NK
    Proc Soc Exp Biol Med; 1953 Jun; 83(2):216-20. PubMed ID: 13064223
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
    Persson E
    Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the lipolytic system induced in plasma by heparin injection.
    ROBINSON DS
    Q J Exp Physiol Cogn Med Sci; 1956 Apr; 41(2):195-204. PubMed ID: 13485336
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives].
    Millot F; Bara L; Etienne J; Samama M; Laruelle P
    Nouv Rev Fr Hematol (1978); 1987; 29(6):397-400. PubMed ID: 2837726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-released lipolytic and esterolytic activities of human and rabbit plasmas.
    SHORE B; SHORE V
    Am J Physiol; 1961 Nov; 201():915-22. PubMed ID: 13912249
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the plasma free fatty acid composition during VLDL lipolysis induced by heparin: their effect on platelet phosphatidylcholine biosynthesis.
    Tavella JM; Tournier H; Schinella G; de Bravo MG; De Tomás ME; Mercuri O
    Biomed Biochim Acta; 1988; 47(8):725-30. PubMed ID: 3240303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment.
    Persson E; Nordenström J; Nilsson-Ehle P; Hagenfeldt L; Wahren J
    Clin Physiol; 1990 Nov; 10(6):573-83. PubMed ID: 1964632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-heparin triacylglycerol lipases in ovine plasma.
    Tume RK; Thornton RF; Johnson GW
    Aust J Biol Sci; 1988; 41(2):215-21. PubMed ID: 3270309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buccal and sublingual administration of heparin potassium (clarin); studies of plasma triglyceride lipolysis and heparin levels.
    ENGELBERG H
    J Am Med Assoc; 1959 Mar; 169(12):1322-5. PubMed ID: 13630759
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation.
    Eckel RH; Goldberg IJ; Steiner L; Yost TJ; Paterniti JR
    Diabetes; 1988 May; 37(5):610-5. PubMed ID: 3360217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment.
    Persson E; Nordenström J; Hagenfeldt L; Nilsson-Ehle P
    Thromb Res; 1987 Jun; 46(5):697-704. PubMed ID: 3629543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the intravenous administration of homologous albumin on the lipolytic enzyme activity of rabbit blood plasma].
    Soliternova IB; Nikul'cheva NG; Sanches Serrano D
    Vopr Med Khim; 1984; 30(2):87-91. PubMed ID: 6740999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total parenteral nutrition with intralipid in premature infants receiving TPN with heparin: effect on plasma lipolytic enzymes, lipids, and glucose.
    Berkow SE; Spear ML; Stahl GE; Gutman A; Polin RA; Pereira GR; Olivecrona T; Hamosh P; Hamosh M
    J Pediatr Gastroenterol Nutr; 1987; 6(4):581-8. PubMed ID: 3123635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipolytic effects of heparin].
    REINHARDT F
    Wien Z Inn Med; 1956 Mar; 37(3):126-30. PubMed ID: 13338296
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of a low molecular weight heparin derivative on the release of lipolytic activity in the blood].
    Millot F; Etienne J; Aiach M; Meyniel D; Brault D; Piéron R; Laruelle P
    C R Seances Acad Sci III; 1982 Dec; 295(13):771-4. PubMed ID: 6820311
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of thyroxine on the plasma post-heparin lipolytic activity in rats.
    Skottová N; Palkovic M
    Horm Metab Res; 1980 Feb; 12(2):74-6. PubMed ID: 7372269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin.
    Hakala JK; Oörni K; Ala-Korpela M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1276-83. PubMed ID: 10323780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some physical and chemical properties of the lipoproteins produced by lipolysis of human serum Sf 20-400 lipoproteins by post-heparin plasma.
    SHORE B; SHORE V
    J Atheroscler Res; 1962; 2():104-14. PubMed ID: 13912251
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagon action upon plasma post-heparin lipolytic and monoglyceride hydrolase activities. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    de Basilico MZ; Castro G; Nusimovich B; de Lombardo YB
    Biomedicine; 1980 Nov; 33(7):213-6. PubMed ID: 6112026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipolytic effects of heparin and low molecular weight heparin and their importance in hemodialysis.
    Schrader J; Andersson LO; Armstrong VW; Kundt M; Stibbe W; Scheler F
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():41-5. PubMed ID: 1962903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.